The Real Chemistry Podcast

Biotech investor, scientist and author Peter Kolchinsky, Ph. D. joins the show with our Founder and Chairman, Jim Weiss, to discuss what the passing of the Prescription Drug Pricing Reform bill would mean for our industry.

Making health information more approachable, simple and easy to understand will improve health literacy and ultimately improve patient outcomes. Dr. Geeta Nayyar, Chief Medical Officer of Salesforce, joins the show to discuss health misinformation and her takeaways from the Life Itself conference, plus she shares her love of U2.

Unpaid caregiving can often feel like a thankless job. This week’s guest, Alexandra Drane, is here to change that with her organization ARCHANGELS.

Securing justice and fair treatment for all is at the core of what Anti-Defamation League’s work. Jonathan Greenblatt, CEO & National Director of the ADL, discusses how we can fight all forms of hate for good with Jim Weiss, Real Chemistry Founder & Chairman.

Patients, caregivers, and their communities are at the center of our work, and nobody is a better advocate for these individuals than Sally Schaeffer our, VP of Community Engagement Strategy. In this episode, Sally tells her heartbreaking yet inspiring story of advocating for Sudden Unexpected Death in Epilepsy (SUDEP), learning how to be there for those experiencing grief, and sharing patients’ a...

Our guest this week is an expert in harnessing the voices of trusted scientific sources to spread vital health information. Action 314’s Founder and President, Shaughnessy Naughton, sits down to discuss why electing scientific and health care experts to our government re-builds trust during turbulent times.

The cancer landscape is evolving at record speed – and so too are the expectations and experiences of attendees at the annual ASCO (American Society for Clinical Oncology) meeting, held annually in Chicago from June 3-7. Join Real Chemistry’s Jennifer Paganelli, Ujwal Pyati, and Brandon Pletsch, some our medical, media and creative experts, as they dissect trends shaping the optimal “art & science...

We’re back with Dr. Monica Gandhi and our own Jim Weiss! We’ve loved checking in with these two about the current state of COVID-19, and this time, they delivered an uplifting assessment and a ton of recent data and studies to back it up.

Last week, Elon Musk bought Twitter, plunging the platform and our role in it into an uncertain future. At the highest level, what could this mean for health care communicators, practitioners, and patients looking for information? We sat down with our own social media experts, Chuck Hemann, Anke Knospe, and Jurgen Castro to hear their expert opinions.

We’re diving into a new topic on the podcast: menstrual health. Lauren Wang, Founder and CEO of The Flex Company, discusses how her company innovates in health care and makes periods a more normal and empathetic topic in everyday life. Plus, she shares her expert advice for female entrepreneurs pitching to a room full of men.  

Our CEO, Shankar Narayanan, joins us for this week’s show. He opens up about why he joined Real Chemistry and shares where the industry and our organization are headed.  Plus, he shares his ideal mixtape that will definitely give you earbud envy.

Check out the first episode of the year with Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research, FDA, and Jim Weiss, our Founder, and Chairman! Learn about how the US is evolving to living with an endemic, the role of communications for the FDA, and what's in store for the next generation of therapies.

As we head into the holiday season, there are a lot of questions and concerns about the Omicron variant. Dr. Monica Gandhi, Professor of Medicine at UCSF, joins the show to unpack the nuances of Omicron and share why she's optimistic about where we are in the pandemic.

The year's final episode is here, and we saved the best for last! Dr. Scott Gottlieb, former FDA Commissioner, chats with Jim Weiss, our Founder & Chairman, about lessons learned from COVID-19, how variants will impact our future (i.e., JP Morgan 2022), and how we can prepare for the next pandemic.

It's a family affair on this week's episode of the show! Our Global Head of Facilities, Beth Weiss, and Jim Weiss, our Founder, and CEO, join the show to chat about Beth's coming out journey and the importance of living as your authentic self.

Curious about the basics of market access and value? Amy Grogg, PharmD, one of our CEO Advisory Board Members, joins the show to unpack all things market access and value. Plus, she dives into her appreciation of Green Day.

If Sung Poblete had one wish, it would be to put her company out of business because cancer as we know it is no more. The President & CEO of Stand Up to Cancer joins the show to discuss the mission of making every cancer patient a long-term survivor and shares her admiration of Rufus Wainwright.

This week's guest is a true changemaker and force for good in healthcare. Maimah Karmo, President & CEO of the Tigerlily Foundation joins the show to discuss how she's advocating and driving actionable solutions in our industry. Plus, she shares her love of Michael Jackson’s Thriller album.

She’s back! Mary Stutts, Chief Global Inclusion & Health Equity Officer of Real Chemistry, joins the show again to discuss how to integrate health equity into everything you do.

Health data is medicine, according to Ardy Arianpour, CEO & Co-Founder of Seqster. Ardy is joined by Real Chemistry’s Larry Mickelberg to discuss how we can break down health data silos and what that would mean for the future of healthcare.

Co-Creator of TEDMED and Founder & Co-Host, LIFE ITSELF, with Dr. Sanjay Gupta, Marc Hodosh, joins the show to discuss his upcoming health conference and the genesis of TEDMED. Plus, he shares why he'd bring a CD with him on a deserted island.

We can’t undo 400 years of systemic racism in a week, creating equitable healthcare takes a movement not a moment. André Blackman, Founder & CEO of Onboard Health & Abby Hayes, Practice Leader of DE&I Engagement, Real Chemistry join this week’s episode to discuss designing an equitable healthcare system.

New name, same ethos.

It is an honor to have Sandra Lindsay, a critical care nurse, and the first person in the US to receive the COVID-19 vaccine join our show. As a healthcare hero, she opens up about her frontline experience and the importance of vaccinations, plus she discusses her appreciation of Bob Marley.

Doubling the survival rate of pancreatic cancer is an ambitious goal but a noble one. Julie Fleshman joins the show to discuss how her organization, PanCAN, is ensuring a world in which all pancreatic cancer patients will thrive.